Mismatch repair deficiency, chemotherapy and survival for resectable gastric cancer: an observational study from the German staR cohort and a meta-analysis von Stolze, T., Franke, S., Haybaeck, J., Moehler, M., Grimminger, P. P., Lang, H., Roth, W., Gockel, I., Kreuser, N., Bläker, H., Wittekind, C., Lordick, F., Vieth, M., Veits, L., Waidmann, O., Lingohr, P., Peitz, U., Schildberg, C., Kruschewski, M., Vassos, N., Goni, E., Bruns, C. J., Ridwelski, K., Wolff, S., Lippert, H., Schumacher, J., Malfertheiner, P., Venerito, M.

Volltext

Functional characterization of the tumor-suppressor MARCKS in colorectal cancer and its association with survival von Bickeböller, M, Tagscherer, K E, Kloor, M, Jansen, L, Chang-Claude, J, Brenner, H, Hoffmeister, M, Toth, C, Schirmacher, P, Roth, W, Bläker, H

Volltext

Microsatellite instability in colorectal cancer is associated with local lymphocyte infiltration and low frequency of distant metastases von BUCKOWITZ, A, KNAEBEL, H.-P, BENNER, A, BLÄKER, H, GEBERT, J, KIENLE, P, VON KNEBEL DOEBERITZ, M, KLOOR, M

Volltext

Predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance von Dietel, M, Jöhrens, K, Laffert, Mv, Hummel, M, Bläker, H, Müller, B M, Lehmann, A, Denkert, C, Heppner, F L, Koch, A, Sers, C, Anagnostopoulos, I

Volltext

A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance von Dietel, M, Jöhrens, K, Laffert, M V, Hummel, M, Bläker, H, Pfitzner, B M, Lehmann, A, Denkert, C, Darb-Esfahani, S, Lenze, D, Heppner, F L, Koch, A, Sers, C, Klauschen, F, Anagnostopoulos, I

Volltext

SPARC expression in resected pancreatic cancer patients treated with Gemcitabine: results from the CONKO-001 study von Sinn, M, Sinn, B V, Striefler, J K, Lindner, J L, Stieler, J M, Lohneis, P, Bischoff, S, Bläker, H, Pelzer, U, Bahra, M, Dietel, M, Dörken, B, Oettle, H, Riess, H, Denkert, C

Volltext

Transgenic expression of oncogenic BRAF induces loss of stem cells in the mouse intestine, which is antagonized by [beta]-catenin activity von Riemer, P, Sreekumar, A, Reinke, S, Rad, R, Schafer, R, Sers, C, Blaker, H, Herrmann, B.G, Morkel, M

Volltext

Mutational activation of the RAS-RAF-MAPK and the wnt pathway in small intestinal adenocarcinomas von Bläker, H., Helmchen, B., Bönisch, A., Aulmann, S., Penzel, R., Otto, H. F., Rieker, R. J.

Volltext

Confidence curves and improved exact confidence intervals for discrete distributions von Blaker, Helge

Volltext

P1-508 Oestrogen receptor   expression in colorectal cancer von Rudolph, A., Toth, C., Hein, R., Hoffmeister, M., Herpel, E., Blaker, H., Brenner, H., Chang-Claude, J.

Volltext

Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal surface malignancies (PSM): a prospective single-center registry study von Jansen-Winkeln, B., Eberth, J., Moulla, Y., Mehdorn, M., Niebisch, S., Schierle, K., Bläker, H., Lordick, F., Gockel, I., Thieme, R.

Volltext

SPARC expression in resected pancreatic cancer patients treated with gemcitabine: results from the CONKO-001 study von Sinn, M., Sinn, B.V., Striefler, J.K., Lindner, J.L., Stieler, J.M., Lohneis, P., Bischoff, S., Bläker, H., Pelzer, U., Bahra, M., Dietel, M., Dörken, B., Oettle, H., Riess, H., Denkert, C.

Volltext

Human equilibrative nucleoside transporter 1 expression analysed by the clone SP 120 rabbit antibody is not predictive in patients with pancreatic cancer treated with adjuvant gemc... von Sinn, M, Riess, H, Sinn, B.V, Stieler, J.M, Pelzer, U, Striefler, J.K, Oettle, H, Bahra, M, Denkert, C, Bläker, H, Lohneis, P

Volltext

Frequency of therapy-relevant staging shifts in colorectal cancer through the introduction of pN1c in the 7th TNM edition von von Winterfeld, M, Hoffmeister, M, Ingold-Heppner, B, Jansen, L, Tao, S, Herpel, E, Schirmacher, P, Dietel, M, Chang-Claude, J, Autschbach, F, Brenner, H, Bläker, H

Volltext

Transgenic expression of oncogenic BRAF induces loss of stem cells in the mouse intestine, which is antagonized by β-catenin activity von Riemer, P, Sreekumar, A, Reinke, S, Rad, R, Schäfer, R, Sers, C, Bläker, H, Herrmann, B G, Morkel, M

Volltext

Corrections to “SPARC expression in resected pancreatic cancer patients treated with Gemcitabine: results from the CONKO-001 study” von Sinn, M., Sinn, B.V., Striefler, J.K., Lindner, J.L., Stieler, J.M., Lohneis, P., Bischoff, S., Bläker, H., Pelzer, U., Bahra, M., Dietel, M., Dörken, B., Oettle, H., Riess, H., Denkert, C.

Volltext

A reliable risk score for stage IV esophagogastric cancer von Blank, S, Lordick, F, Dobritz, M, Grenacher, L, Burian, M, Langer, R, Roth, W, Schaible, A, Becker, K, Bläker, H, Sisic, L, Stange, A, Compani, P, Schulze-Bergkamen, H, Jäger, D, Büchler, M, Siewert, J.R, Ott, K

Volltext

685: Linking tumor evolution and therapy response using diagnostic targeted next generation sequencing in colorectal cancer von Mamlouk, S, Childs, L, Redmer, T, Bläker, H, Aust, D, Schäfer, R, Sers, C

Volltext

Large-scale N-terminal deletions but not point mutations stabilize β-catenin in small bowel carcinomas, suggesting divergent molecular pathways of small and large intestinal carcin... von Breuhahn, K, Singh, S, Schirmacher, P, Bläker, H

Volltext

State of the Art in der Therapie des Kolonkarzinoms von Ghadimi, M, Reinacher-Schick, A, Bläker, H, Höffken, K

Volltext